TABLE 3.

Network meta-analysis comparisons for acceptability.

Placebo
0.89 (0.77, 0.99)	NSAIDs
0.89 (0.64, 1.04)	1.00 (0.72, 1.23)	Corticosteroids
0.97 (0.87, 1.08)	1.09 (0.93, 1.3)	1.09 (0.9, 1.54)	Statins
0.94 (0.75, 1.11)	1.06 (0.83, 1.31)	1.06 (0.8, 1.52)	0.97 (0.76, 1.18)	Pioglitazone
1.08 (0.95, 1.25)	1.22 (1.03, 1.49)	1.22 (0.99, 1.72)	1.11 (0.94, 1.34)	1.15 (0.93, 1.51)	Minocycline
0.92 (0.79, 1.08)	1.04 (0.86, 1.28)	1.04 (0.83, 1.48)	0.95 (0.78, 1.15)	0.98 (0.78, 1.29)	0.85 (0.69, 1.05)	NACs
0.98 (0.93, 1.02)	1.10 (0.99, 1.28)	1.10 (0.94, 1.52)	1.01 (0.90, 1.14)	1.04 (0.88, 1.31)	0.91 (0.78, 1.04)	1.07 (0.90, 1.25)	Omega-3 FA

Data are RRs (95% CI) in the column-defining treatment compared with the row-defining treatment. RRs higher than 1 favour the column-defining treatment. RRs lower than 1 favour the row-defining treatment. Significant results are in bold. NSAIDs: non-steroidal anti-inflammatory drugs; NACs: N-acetylcysteines; Omega-3 FA: omega-3 fatty acid.